Skip to Content


Pediatric Stakeholder Meeting; Request for Comments; Correction

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Food and Drug Administration, HHS.


Notice; correction.


The Food and Drug Administration is correcting a document entitled “Pediatric Stakeholder Meeting; Request for Comments” that appeared in the Federal Register of February 26, 2015 (80 FR 10493). The document announced a public meeting seeking input from patient groups, consumer groups, regulated industry, academia and other interested parties to obtain any recommendations or information relevant to the report to Congress that FDA is required to submit concerning pediatrics, as outlined in the Food and Drug Administration Safety and Innovation Act (FDASIA). The document was published with the incorrect docket number. This document corrects that error.

Start Further Info


Lisa Granger, Office of Policy, Planning, Legislation, and Analysis, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993, 301-796-9115.

End Further Info End Preamble Start Supplemental Information


In the Federal Register of February 26, 2015, in FR Doc. 2015-03974, on page 10493, the following correction is made:

On page 10493, in the first column, the Docket No. heading, “[Docket No. FDA-20115-N-0456]” is corrected to read “[Docket No. FDA-2015-N-0456]”.

Start Signature

Dated: March 17, 2015.

Jill Hartzler Warner,

Associate Commissioner for Special Medical Programs.

End Signature End Supplemental Information

[FR Doc. 2015-06426 Filed 3-19-15; 8:45 am]